课题基金 / 基金详情

Asymmetric Synthesis of Macrolide Antibiotics

Asymmetric Synthesis of Macrolide Antibiotics
大环内酯类抗生素的不对称合成
批准号:
6542310
负责人:
JAMES L LEIGHTON
金额:
$33.49万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2006-07-31

项目摘要

项目成果

JAMES L LEIGHTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal details the development of new, catalytic reaction methodology for the efficient asymmetric synthesis of polyacetate- and polypropionate-derived macrolide antibiotics, It has been documented that drug-resistant bacterial and fungal infections represent a problem of rapidly growing importance. More than simply achieving syntheses of such compounds, the focus of the proposal is on advancing the frontiers of efficiency, waste-minimization and economic viability of such synthetic efforts. The ultimate goal is thus the realization of practicable and practical chemistry that will affect both the discovery and process phases of research into new medicinal agents. This proposal addresses both the continuation and further development of the most promising discoveries made in the previous funding period, as well as exciting new directions only recently initiated. The reactions under study have as their unifying theme tandem reaction methodology. Tandem reactions are inherently more efficient as multiple chemical transformations may be accomplished, and multiple stereogenic centers may be established in a single operation. In this fashion, large segments of the target natural products may be synthesized with unprecedented efficiency employing only readily available and environmentally benign reagents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Asymmetric Synthesis of Macrolide Antibiotics
TOTAL SYNTHESIS OF RAS FARNESYL TRANSFERASE INHIBITOR
TOTAL SYNTHESIS OF THE FARNESY TRANSFERASE INHIBITOR
TOTAL SYNTHESIS OF THE FARNESY TRANSFERASE INHIBITOR
国内基金
海外基金
2D co-catalyst/TiO2{001}协同光催化甲烷制C2+液态含氧化合物
  • 批准号:
    22302187
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    孙潇
  • 依托单位: